Shawn A. Ritchie
Prince Albert, SK, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
First-In-Human Safety, Tolerability, and Pharmacokinetics of PPI-1011, a Synthetic Plasmalogen Precursor.
Journal: Clinical and translational science
Published: January 13, 2025
Development and evaluation of RhizoQOL, a quality-of-life caregiver-reported survey for rhizomelic chondrodysplasia punctata, a rare peroxisomal disorder.
Journal: Orphanet journal of rare diseases
Published: June 27, 2024
Pharmacokinetics, Mass Balance, Excretion, and Tissue Distribution of Plasmalogen Precursor PPI-1011.
Journal: Frontiers in cell and developmental biology
Published: January 31, 2022
Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata.
Journal: Orphanet journal of rare diseases
Published: February 05, 2021
Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of rhizomelic chondrodysplasia punctata.
Journal: Disease models & mechanisms
Published: October 03, 2019
Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor.
Journal: Brain research
Published: July 09, 2019
Plasmalogen precursor mitigates striatal dopamine loss in MPTP mice.
Journal: Brain research
Published: July 03, 2017
Improved specificity of serum phosphatidylcholine detection based on side-chain losses during negative electrospray ionization tandem mass spectrometry.
Journal: Analytical and bioanalytical chemistry
Published: June 14, 2016
Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9.
Journal: World journal of gastroenterology
Published: January 07, 2015
Last Updated: 09/26/2026